GlassScriptPhysician profile
Hans H Bauer
NPI 1972582245
$877.37
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $215 · 2021: $114 · 2022: $14.87.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $299.14 | 2019-2021 | |
| Livanova USA, INC. | $188.17 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $115.52 | 2019 | |
| Siemens Medical Solutions USA, INC. | $81.84 | 2020 | |
| Edwards Lifesciences Corporation | $49.41 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $36.73 | 2019-2020 | |
| Cardinal Health 200 LLC | $33.22 | 2019 | |
| Teleflex LLC | $15.13 | 2020 | |
| Abbvie INC. | $14.87 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.70 | 2020 | |
| Amarin Pharma, INC. | $14.32 | 2020 | |
| Abbott Laboratories | $14.32 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hans Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.